The Genetics of Aging: What Large-Scale Studies Are Revealing

1. Aging and Longevity Are Highly Polygenic Human aging and longevity are influenced by many genetic variants across the genome, rather than by a single gene. Most variants have small individual effects, but together they contribute to differences in how people age and how long they live. 2.Lifespan and Healthspan Share Genetic Influences-but Are Not Identical GWAS of lifespan, longevity and healthspan show both shared and distinct genetic signals. This suggests that living longer and remaining healthy for longer are closely related, but do not have exactly the same genetic architecture.

3. Some Genetic Signals Appear Repeatedly Across large-scale studies, several loci-including APOE, LPA, CHRNA5, FOXO3, SH2B3 and CDKN2B-AS1-have repeatedly appeared in studies of aging and longevity-related traits. Together, they point toward biological processes involving metabolism, immune regulation and cellular signaling, rather than a single genetic mechanism of longevity.

4. Different Genes Converge on Common Biological Processes Despite the large number of variants involved, many genetic signals point toward common biological processes, including lipid metabolism, inflammation, insulin/IGF signaling and DNA repair. T This suggests that understanding these shared biological processes may be more informative than focusing on individual genetic variants alone.

5. Genetics Still Explains Only Part of Longevity Variants identified through GWAS account for only a limited proportion of the estimated heritable component of longevity. Rare and structural variants, gene regulation, gene-environment interactions and other biological influences may help explain part of what remains unknown.

6. Genetic Effects Can Differ Between Populations Many longevity GWAS have been conducted predominantly in populations of European ancestry, limiting how broadly some findings can be applied. Larger and more diverse populations are essential for identifying genetic effects that may differ across ancestries.

7. Genetics Cannot Yet Reliably Predict Individual Lifespan Even very large genomic datasets cannot currently tell us how long a particular person will live. The value of GWAS lies primarily in revealing biological mechanisms and patterns of risk, rather than providing an individual lifespan prediction.

Large-scale genetic studies show that human longevity is shaped by many genetic influences rather than a small number of “longevity genes.” Importantly, these genetic signals repeatedly point toward key biological processes involved in aging, including lipid metabolism, inflammation, insulin/IGF signaling and DNA repair. This helps researchers understand not only which genes are associated with longevity, but which biological processes may influence healthy aging and resilience to age-related disease.

The distinction between lifespan and healthspan is also important: the genetics of living longer may not be identical to the genetics of remaining healthy for longer.

For longevity medicine, the main value of genetic research is therefore understanding why people age differently and identifying biological mechanisms that may contribute to healthier aging-not predicting individual lifespan.

For clinicians, longevity genetics can provide information about inherited susceptibility to age-related disease, but its ability to predict how an individual patient will age remains limited.

Individual variants and polygenic risk scores may help identify genetic risk, but they should not be interpreted as measures of “longevity potential” or predictions of lifespan. Their interpretation is also limited by differences between populations and the still incomplete understanding of longevity genetics.

In current practice, genetic information should therefore complement-not replace-family history, cardiovascular and metabolic risk assessment, lifestyle, physical and cognitive function, and other validated clinical measures.

As genetic research improves, it may increasingly support personalized prevention and risk assessment. For now, its greatest clinical value is understanding inherited risk-not predicting how long a patient will live.